Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve-Reference-Cited by-同舟云学术

Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve

Published:2020-10 Issue: Volume:138 Page:156-168
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Guberina Nika,Pöttgen Christoph,Schuler Martin^ORCID,Guberina Maja,Stamatis Georgios,Plönes Till,Krebs Bettina,Metzenmacher Martin,Theegarten Dirk,Gauler Thomas,Jöckel Karl-Heinz,Darwiche Kaid,Aigner Clemens^ORCID,Stuschke Martin,Eberhardt Wilfried E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Clinical practice guidelines in oncology;Non-Small Cell Lung Cancer,2019

2. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Kozower;Chest,2013

3. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Kozower;Chest,2013

4. The eighth edition lung cancer stage classification;Detterbeck;Chest,2017

5. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol : official publication of the International Association for the Study of Lung Cancer,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

2. Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors;Immunotherapy;2022-08

3. Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment;Radiation Oncology;2022-07-16

4. Correlation between outcomes and tumor size in >7 cm T4 non-small cell lung cancer patients: A tumor size-based comparison study;Asian Cardiovascular and Thoracic Annals;2021-08-23

5. The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art;Cancers;2021-07-23